UBIO

Proshares UltraPro NASDAQ Biotechnology

Delisted

UBIO was delisted on the 27th of March, 2020.

6 hedge funds and large institutions have $1.25M invested in Proshares UltraPro NASDAQ Biotechnology in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
1
Closed
4
Calls
$239K
Puts
$506K
Net Calls
-$267K
Net Calls Change
-$584K
Name Holding Trade Value Shares
Change
Shares
Change %
VF
1
Virtu Financial
New York
$721K +$721K +22,644 New
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$459K -$155K -4,865 -25%
Morgan Stanley
3
Morgan Stanley
New York
$29K +$19.4K +606 +202%
LTFS
4
Ladenburg Thalmann Financial Services
Florida
$23K +$23K +720 New
CG
5
Cutler Group
California
$12K
AIM
6
Anchor Investment Management
South Carolina
$8.75K +$8.75K +275 New
TRCT
7
Tower Research Capital (TRC)
New York
-$1.28M -38,065 Closed
ACM
8
Avalon Capital Management
California
-$818K -24,329 Closed
Jane Street
9
Jane Street
New York
-$527K -15,656 Closed
UBS Group
10
UBS Group
Switzerland
-$101K -3,003 Closed